Yoshiki Hatsumi, Nishimune Atsushi, Suzuki Fumiko, Morishima Shigeru, Ikeda Takeshi, Sasaki Masato, Audigane Leslie M, Gauthier Chantal, Muramatsu Ikunobu
Division of Pharmacology, Department of Biochemistry and Bioinformative Sciences, School of Medicine, University of Fukui, Fukui, Japan.
J Pharmacol Sci. 2009 Jul;110(3):389-96. doi: 10.1254/jphs.09147fp. Epub 2009 Jul 3.
[(3)H]-CGP12177 biphasically bound to beta-adrenoceptors with high and low affinities in the segments and crude membranes of rabbit left ventricle. The low-affinity sites for [(3)H]-CGP12177 in the segments was double in density, compared to the density of high-affinity sites. Total abundance of the beta-adrenoceptors decreased to approximately 10% upon tissue homogenization, and the proportion of low-affinity sites was the same as that of the high-affinity sites in the membranes. The majority of the high-affinity binding sites of [(3)H]-CGP12177 in the segments and the membranes were beta(1H)-adrenoceptor, being highly sensitive to propranolol and beta(1)-antagonists (atenolol and ICI-89,406), whereas the low-affinity binding sites showed a beta(1L)-profile (less sensitive to propranolol and beta(1)-, beta(2)-, and beta(3)-antagonists). Furthermore, a part of the beta(1L)-adrenoceptors was insensitive to atenolol, ICI-89,406, and/or isoproterenol. The present binding study clearly shows that beta(1L)-adrenoceptors occur as a distinct phenotype from beta(1H)-adrenoceptors in rabbit ventricle. However, quantitative imbalance between beta(1H)- and beta(1L)-adrenoceptors and divergent ligand-beta(1L)-adrenoceptor interactions suggest a possibility that the beta(1L)-adrenoceptor may not reflect a simple conformational change or allosteric state in the beta(1)-adrenoceptor molecule.
[³H]-CGP12177以高亲和力和低亲和力双相结合于兔左心室节段和粗制膜中的β-肾上腺素能受体。与高亲和力位点的密度相比,节段中[³H]-CGP12177的低亲和力位点密度增加了一倍。组织匀浆后,β-肾上腺素能受体的总丰度降至约10%,膜中低亲和力位点与高亲和力位点的比例相同。节段和膜中[³H]-CGP12177的大多数高亲和力结合位点是β(1H)-肾上腺素能受体,对普萘洛尔和β(1)-拮抗剂(阿替洛尔和ICI-89,406)高度敏感,而低亲和力结合位点呈现β(1L)特征(对普萘洛尔以及β(1)-、β(2)-和β(3)-拮抗剂敏感性较低)。此外,一部分β(1L)-肾上腺素能受体对阿替洛尔、ICI-89,406和/或异丙肾上腺素不敏感。目前的结合研究清楚地表明,β(1L)-肾上腺素能受体在兔心室中作为一种与β(1H)-肾上腺素能受体不同的表型存在。然而,β(1H)-和β(1L)-肾上腺素能受体之间的定量失衡以及配体与β(1L)-肾上腺素能受体的不同相互作用表明,β(1L)-肾上腺素能受体可能并不反映β(1)-肾上腺素能受体分子中的简单构象变化或变构状态。